Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19


Comparison of Globus Pallidus Interna and Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease: An Institutional Experience and Review.

Mirza S, Yazdani U, Dewey Iii R, Patel N, Dewey RB Jr, Miocinovic S, Chitnis S.

Parkinsons Dis. 2017;2017:3410820. doi: 10.1155/2017/3410820. Epub 2017 Jun 19. Review.


Roles of Multiple Globus Pallidus Territories of Monkeys and Humans in Motivation, Cognition and Action: An Anatomical, Physiological and Pathophysiological Review.

Saga Y, Hoshi E, Tremblay L.

Front Neuroanat. 2017 Apr 10;11:30. doi: 10.3389/fnana.2017.00030. eCollection 2017. Review.


Neuropsychiatric Symptoms in Parkinson's Disease: Beyond Complications.

Kehagia AA.

Front Psychiatry. 2016 Jun 23;7:110. doi: 10.3389/fpsyt.2016.00110. eCollection 2016. No abstract available.


Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Sarkar S, Raymick J, Imam S.

Int J Mol Sci. 2016 Jun 8;17(6). pii: E904. doi: 10.3390/ijms17060904. Review.


A Novel Lead Design for Modulation and Sensing of Deep Brain Structures.

Connolly AT, Vetter RJ, Hetke JF, Teplitzky BA, Kipke DR, Pellinen DS, Anderson DJ, Baker KB, Vitek JL, Johnson MD.

IEEE Trans Biomed Eng. 2016 Jan;63(1):148-57. doi: 10.1109/TBME.2015.2492921. Epub 2015 Oct 28.


Long-term neuropsychiatric outcomes after pallidal stimulation in primary and secondary dystonia.

Meoni S, Zurowski M, Lozano AM, Hodaie M, Poon YY, Fallis M, Voon V, Moro E.

Neurology. 2015 Aug 4;85(5):433-40. doi: 10.1212/WNL.0000000000001811. Epub 2015 Jul 8.


Mixed effects of deep brain stimulation on depressive symptomatology in Parkinson's disease: a review of randomized clinical trials.

Gökbayrak NS, Piryatinsky I, Gavett RA, Ahmed OJ.

Front Neurol. 2014 Aug 11;5:154. doi: 10.3389/fneur.2014.00154. eCollection 2014. Review.


STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Williams NR, Foote KD, Okun MS.

Mov Disord Clin Pract. 2014 Apr 1;1(1):24-35.


Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Williams NR, Okun MS.

J Clin Invest. 2013 Nov;123(11):4546-56. doi: 10.1172/JCI68341. Epub 2013 Nov 1. Review.


Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

Campbell MC, Black KJ, Weaver PM, Lugar HM, Videen TO, Tabbal SD, Karimi M, Perlmutter JS, Hershey T.

J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):28-36. doi: 10.1176/appi.neuropsych.11030060.


Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Smith Y, Wichmann T, Factor SA, DeLong MR.

Neuropsychopharmacology. 2012 Jan;37(1):213-46. doi: 10.1038/npp.2011.212. Epub 2011 Sep 28. Review.


DBS candidates that fall short on a levodopa challenge test: alternative and important indications.

Morishita T, Rahman M, Foote KD, Fargen KM, Jacobson CE 4th, Fernandez HH, Rodriguez RL, Malaty IA, Bowers D, Hass CJ, Katayama Y, Yamamoto T, Okun MS.

Neurologist. 2011 Sep;17(5):263-8. doi: 10.1097/NRL.0b013e31822d1069.


Deep brain stimulation in Parkinson's disease.

Groiss SJ, Wojtecki L, Südmeyer M, Schnitzler A.

Ther Adv Neurol Disord. 2009 Nov;2(6):20-8. doi: 10.1177/1756285609339382.


Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies.

Morishita T, Foote KD, Burdick AP, Katayama Y, Yamamoto T, Frucht SJ, Okun MS.

Parkinsonism Relat Disord. 2010 Mar;16(3):153-62. doi: 10.1016/j.parkreldis.2009.10.003. Epub 2009 Nov 5. Review.


Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.

Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F, Suelter M, Jacobson CE 4th, Wang X, Gordon CW Jr, Zeilman P, Romrell J, Martin P, Ward H, Rodriguez RL, Foote KD.

Ann Neurol. 2009 May;65(5):586-95. doi: 10.1002/ana.21596.


Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming.

Okun MS, Mann G, Foote KD, Shapira NA, Bowers D, Springer U, Knight W, Martin P, Goodman WK.

J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):310-4. Epub 2006 Sep 29.


Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.

Capecci M, Ricciuti RA, Burini D, Bombace VG, Provinciali L, Iacoangeli M, Scerrati M, Ceravolo MG.

J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):769-74.


Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?

Minguez-Castellanos A, Escamilla-Sevilla F, Katati MJ, Martin-Linares JM, Meersmans M, Ortega-Moreno A, Arjona V.

J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):34-9.

Supplemental Content

Support Center